CURE - Oncology & Cancer News for Patients & Caregivers
CURE - Oncology & Cancer News for Patients & Caregivers
Spotlight
BlogsCancer HorizonsClinical Trial CornerCURE's 20th Anniversary CelebrationPublicationsRecipesVideos
Cancer Type
View MoreBladderBreastCLLKidneyLungMCLOvarianProstateSkin
About CURE
Press ReleasesShare Your StoryWrite for CURE
News
Cancer Horizons
All News
Blogs
Caregiving
Diet and Exercise
Financial
Psychosocial
Recipes
Sexual Health
Side Effect
Sponsored
Survivorship
Videos
All Videos
CURE Connections
CURE Expert Connections
CURE Speaking Out
CURE TV
On Demand: Award Programs
On Demand: Patient Summits
On Demand: Webinars
Conferences
Conference Coverage
Conference Listing
Events
CURE Adventures
Award Programs
Educated Patient Summits
Educated Patient Webinars
Resources
Advocacy Groups
Art Gallery
Clinical Trial Corner
CURE Ambassador Program
Educated Patient Research Updates
Interactive Tools
Journey
Partners
Podcasts
Publications
Share Your Story
Subscribe
CURE Magazine
HEAL Magazine
Sign Up for eNews
  • About
  • Advertise / Support
  • Contact
  • CancerNetwork.com
  • TargetedOnc.com
  • OncLive.com
  • OncNursingNews.com
  • Terms & Conditions
  • Privacy
  • Do Not Sell My Information

© 2023 MJH Life Sciences and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.

Cancer Type
Cancer Type
Bladder | Breast | CLL | Kidney | Lung | MCL | Ovarian | Prostate | Skin
View All >>
Spotlight
Spotlight
Blogs | Cancer Horizons | Clinical Trial Corner | CURE's 20th Anniversary Celebration | Publications | Recipes | Videos
Advertisement

Latest News

View All >>

Direct-to-Bladder Immunotherapy Drug to Be Studied in Bladder Cancer

February 1st 2023

By Brielle Benyon

The first patient was dosed with lerapolturev in a phase 1/2 clinical trial evaluating the drug in patients with bladder cancer and other solid tumors.

Chemo Combo Adds More to the Treatment Toolbox for Advanced Pancreatic NETs

February 1st 2023

By Colleen Moretti

A new standard of care for advanced pancreatic neuroendocrine tumors demonstrates improvements in survival and tumor shrinkage.

Anniversary Time: A Look Back of What I’ve Learned 10 Years After Cancer

February 1st 2023

By Julie S. Brokaw

I’m coming up on my 10-year cancer anniversary, and it feels bittersweet.

Taking 8-Plus Medications Before Cancer Treatment May Affect Effectiveness in Older Patients

February 1st 2023

By Darlene Dobkowski, MA

Older patients with advanced cancer who were taking eight or more medications before starting treatment were more likely to discontinue treatment and/or experience a side effect from drug interactions.

CAR-T Cell Therapy May Confer Responses in Relapsed/Refractory CLL or SLL, Preliminary Data Shows

February 1st 2023

By Darlene Dobkowski, MA

The TRANSCNED CLL 004 trial met its primary endpoint of complete responses with the CAR-T cell therapy Breyanzi in patients with relapsed or refractory CLL or SLL.

Blogs

View All >>

Anniversary Time: A Look Back of What I’ve Learned 10 Years After Cancer

February 1, 2023 6:00 PM

By Julie S. Brokaw

Cancer Made Me Superstitious

January 31, 2023 6:00 PM

By Chelsey Gomez

My Dog’s Love Gave Me the Will to Live During Cancer

January 30, 2023 6:00 PM

By Mary Sansone

The Day I Realized My Oncologist Was a Real Person

January 27, 2023 6:00 PM

By Bonnie Annis

Publications

View All >>

Avoiding Unavoidable Carcinogens

January 4, 2023 4:00 PM

The Cancerous Legacy of Environmental Toxins

December 30, 2022 8:00 PM

Cholangiocarcinoma: New Hope for a Rare and Aggressive Cancer

December 30, 2022 2:00 PM

Genetic Targets Open the Door to New Treatment Options in Kidney Cancer

December 29, 2022 8:00 PM

Video Series

View All >>
Oncologists Have Feelings Too: Navigating the Patient Physician Relationship
Debunking Myths of Clinical Trials for Cancer
Highlighting Geographic, Economic Disparities in Cancer Care
Jumping Through Insurance Hoops for Treatment
MF Progression to Acute Myeloid Leukemia and Subsequent Treatment
Myelofibrosis: Novel Treatment Strategies and Combination Therapies
Novel Treatment Strategies in Essential Thrombocythemia and Polycythemia Vera
Adverse Events Tied to Treatment for Myeloproliferative Neoplasms
Healthcare Team Members Involved in Treating Myeloproliferative Neoplasms
Overview of Treatment Options for Myelofibrosis
Overview on the Management of Essential Thrombocythemia and Polycythemia Vera
Educated Patient® MPN Summit Myelofibrosis Panel: November 19, 2022
Educated Patient® MPN Summit Myelofibrosis Second-Line Treatment and Beyond Presentation: November 19, 2022
Educated Patient® MPN Summit First-line Treatment in Myelofibrosis Presentation: November 19, 2022
How Are Myeloproliferative Neoplasms Diagnosed?
Podcasts
View All >>
Creating an Advocacy Group at the Onset of a Global Pandemic: KRAS Kickers Founder Shares Her Story
Childhood Cancer Survivor Pays It Forward at the Same Hospital She Received Treatment
Welireg Made a von Hippel-Lindau Survivor Feel Like a 'Medical Miracle'
Creating a Charity 8 Days After a Rare Cancer Diagnosis: Dying Defiantly Founder Shares His Story
A Nurse and Parent Explains Navigating Pediatric Oncology During COVID-19
From a 15-Month Prognosis to 17 Years of Survivorship: Heather Von St. James' Mesothelioma Story
Writing a Book Helped a Survivor Process Fears of Cancer Recurrence
From Volunteer to Patient to Advocate: How a Breast Cancer Survivor’s Life Has Changed Over the Years
Reading the Fine Print: How a Footnote on a CT Scan Led to an Unexpected Lung Cancer Diagnosis
Patient With Lung Cancer ‘Stays One Step Ahead’ of His Rare Mutation

Share Your Story

View All >>

As Rare Disease Day Approaches, I’m Reflecting on My MPN Diagnosis

January 28, 2023 7:00 PM

By Wendy Reichental

Is There a Scale for Cancer Survivorship?

January 26, 2023 2:00 PM

By Stephanie Landon

Cancer Is Like a Race, and I’m Determined to Win

January 25, 2023 4:00 PM

By Shoba Rao

Wondering ‘Why Me’ After a Cancer Diagnosis

January 23, 2023 8:00 PM

By John Smelcer, PhD, CAGS

Advertisement
  Advocacy Group Content

Advocacy Group Content

Direct-to-Bladder Immunotherapy Drug to Be Studied in Bladder Cancer

Chemo Combo Adds More to the Treatment Toolbox for Advanced Pancreatic NETs

Anniversary Time: A Look Back of What I’ve Learned 10 Years After Cancer

Taking 8-Plus Medications Before Cancer Treatment May Affect Effectiveness in Older Patients

View More Advocacy Group Content
Advertisement
  • About
  • Advertise / Support
  • Contact
  • Terms & Conditions
  • Privacy
  • Do Not Sell My Information
  • Write
  • Press Release
  • CancerNetwork.com
  • TargetedOnc.com
  • OncLive.com
  • OncNursingNews.com

© 2023 MJH Life Sciences™ and CureToday. All rights reserved.